The National Pharmaceutical Pricing Authority (NPPA) Friday capped retail prices of 52 more essential medicines, including painkillers and antibiotics.
"The ceiling and retail prices of 52 formulation packs have been fixed or revised under the Drugs Price Control Order (DPCO)," the regulator said in a notification here.
The notice adds the new drugs to the list of about 400 essential medicines, whose prices are administratively controlled by the regulator for making them affordable for the people.
Some of the drugs, made by leading Indian and multinational firms, are used for treating cancer and skin disorders.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app